Clinical Trial Details
EORTC-30991
Back to Clinical Trials Database
Randomized phase III step-up study on initial antiandrogen monotherapy in comparison with watchful waiting in asymptomatic T1-3 any G (any Gleason) N0 or NxM0 prostate cancer patients without local treatment with curative intent.
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 10-Jan-2001 Date Step1 close: 28-Feb-2003 |
| Data management at EORTC | Yes |
| Design |
Phase 3 Randomized open label |
| Targeted Sample size | EORTC Groups: 1266 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/NCT00014586 |
| NCT number | NCT00014586 |
